198 related articles for article (PubMed ID: 2845125)
41. Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site.
Schafer SL; Vlach J; Pitha PM
J Virol; 1996 Oct; 70(10):6937-46. PubMed ID: 8794337
[TBL] [Abstract][Full Text] [Related]
42. Cell-specific differences in activation of NF-kappa B regulatory elements of human immunodeficiency virus and beta interferon promoters by tumor necrosis factor.
Lacoste J; D'Addario M; Roulston A; Wainberg MA; Hiscott J
J Virol; 1990 Oct; 64(10):4726-34. PubMed ID: 2204723
[TBL] [Abstract][Full Text] [Related]
43. Transcriptional activation of human immunodeficiency virus type 1 by herpesvirus infection: an in vivo footprinting study.
Demarchi F; Bovenzi P; Di Luca D; Giacca M
Intervirology; 1996; 39(4):236-41. PubMed ID: 9078464
[TBL] [Abstract][Full Text] [Related]
44. Silencing of human immunodeficiency virus long terminal repeat expression by an adenovirus E1a mutant.
Ventura AM; Arens MQ; Srinivasan A; Chinnadurai G
Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1310-4. PubMed ID: 2137611
[TBL] [Abstract][Full Text] [Related]
45. Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53.
Subler MA; Martin DW; Deb S
J Virol; 1994 Jan; 68(1):103-10. PubMed ID: 8254719
[TBL] [Abstract][Full Text] [Related]
46. Enhancement of the basal-level activity of HIV-1 long terminal repeat by HIV-1 nucleocapsid protein.
Zhang JL; Sharma PL; Crumpacker CS
Virology; 2000 Mar; 268(2):251-63. PubMed ID: 10704334
[TBL] [Abstract][Full Text] [Related]
47. Sequences just upstream of the simian immunodeficiency virus core enhancer allow efficient replication in the absence of NF-kappaB and Sp1 binding elements.
Pöhlmann S; Flöss S; Ilyinskii PO; Stamminger T; Kirchhoff F
J Virol; 1998 Jul; 72(7):5589-98. PubMed ID: 9621017
[TBL] [Abstract][Full Text] [Related]
48. Activation of bovine immunodeficiency-like virus expression by bovine herpesvirus type 1.
Geng Y; Kashanchi F; Wood C
Virology; 1992 Apr; 187(2):832-6. PubMed ID: 1312280
[TBL] [Abstract][Full Text] [Related]
49. Mutational analysis of sodium butyrate inducible elements in the human immunodeficiency virus type I long terminal repeat.
Bohan CA; Robinson RA; Luciw PA; Srinivasan A
Virology; 1989 Oct; 172(2):573-83. PubMed ID: 2800338
[TBL] [Abstract][Full Text] [Related]
50. Natural variants of the HIV-1 long terminal repeat: analysis of promoters with duplicated DNA regulatory motifs.
Koken SE; van Wamel JL; Goudsmit J; Berkhout B; Geelen JL
Virology; 1992 Dec; 191(2):968-72. PubMed ID: 1448931
[TBL] [Abstract][Full Text] [Related]
51. Transactivation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by the human foamy virus bel1 protein requires a specific DNA sequence.
Lee AH; Lee KJ; Kim S; Sung YC
J Virol; 1992 May; 66(5):3236-40. PubMed ID: 1313928
[TBL] [Abstract][Full Text] [Related]
52. Myb protein binds to human immunodeficiency virus 1 long terminal repeat (LTR) sequences and transactivates LTR-mediated transcription.
Dasgupta P; Saikumar P; Reddy CD; Reddy EP
Proc Natl Acad Sci U S A; 1990 Oct; 87(20):8090-4. PubMed ID: 2236022
[TBL] [Abstract][Full Text] [Related]
53. Regulation of HIV-1 gene expression by NF-IL6.
Tesmer VM; Bina M
J Mol Biol; 1996 Sep; 262(3):327-35. PubMed ID: 8844998
[TBL] [Abstract][Full Text] [Related]
54. Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1.
Demarchi F; d'Adda di Fagagna F; Falaschi A; Giacca M
J Virol; 1996 Jul; 70(7):4427-37. PubMed ID: 8676466
[TBL] [Abstract][Full Text] [Related]
55. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
[TBL] [Abstract][Full Text] [Related]
56. Regulation of avian leukosis virus long terminal repeat-enhanced transcription by C/EBP-Rel interactions.
Bowers WJ; Baglia LA; Ruddel A
J Virol; 1996 May; 70(5):3051-9. PubMed ID: 8627783
[TBL] [Abstract][Full Text] [Related]
57. NF-IL6-mediated transcriptional activation of the long terminal repeat of the human immunodeficiency virus type 1.
Tesmer VM; Rajadhyaksha A; Babin J; Bina M
Proc Natl Acad Sci U S A; 1993 Aug; 90(15):7298-302. PubMed ID: 8346247
[TBL] [Abstract][Full Text] [Related]
58. Activation of the human immunodeficiency virus type 1 long terminal repeat by BTEB, a GC box-binding transcription factor.
Imataka H; Mizuno A; Fujii-Kuriyama Y; Hayami M
AIDS Res Hum Retroviruses; 1993 Sep; 9(9):825-31. PubMed ID: 8257632
[TBL] [Abstract][Full Text] [Related]
59. Phorbol ester reduces constitutive nuclear NF kappa B and inhibits HIV-1 production in mature human monocytic cells.
Mufson RA; Myers C; Turpin JA; Meltzer M
J Leukoc Biol; 1992 Dec; 52(6):637-44. PubMed ID: 1464736
[TBL] [Abstract][Full Text] [Related]
60. HSV-1 activation of HIV-1 transcription is augmented by a cellular protein that binds near the initiator element.
Margolis DM; Ostrove JM; Straus SE
Virology; 1993 Jan; 192(1):370-4. PubMed ID: 8390764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]